Literature DB >> 16741569

Cardiac hypertrophy: stressing out the heart.

Jil C Tardiff1.   

Abstract

The question of what differentiates physiological from pathological cardiac hypertrophy remains one of the most clinically relevant questions in basic cardiovascular research. The answer(s) to this question will have far-ranging importance in the fight against hypertrophic heart disease and failure. In this issue of the JCI, Perrino et al. have used a unique model system to mimic the pathophysiologic effects of an intermittent pressure overload on the heart--in effect, to examine the basic issue of what determines an in vivo pathogenic stimulus (see the related article beginning on page 1547). Their findings clearly show that it is the nature of the inciting stimulus, as opposed to chronicity, that establishes the initial pathogenic response and that a distinct disruption of the beta-adrenergic system is centrally involved in the earliest alterations of myocellular physiology. These results suggest both a new paradigm for treatment options in hypertrophic cardiac disease and novel methodologies for further studies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16741569      PMCID: PMC1464918          DOI: 10.1172/JCI28884

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  19 in total

1.  The conserved phosphoinositide 3-kinase pathway determines heart size in mice.

Authors:  T Shioi; P M Kang; P S Douglas; J Hampe; C M Yballe; J Lawitts; L C Cantley; S Izumo
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

Review 2.  Regulation of the circulation during exercise in man.

Authors:  B S Bevegård; J T Shepherd
Journal:  Physiol Rev       Date:  1967-04       Impact factor: 37.312

3.  Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways.

Authors:  Michael A Crackower; Gavin Y Oudit; Ivona Kozieradzki; Renu Sarao; Hui Sun; Takehiko Sasaki; Emilio Hirsch; Akira Suzuki; Tetsuo Shioi; Junko Irie-Sasaki; Rajan Sah; Hai-Ying M Cheng; Vitalyi O Rybin; Giuseppe Lembo; Luigi Fratta; Antonio J Oliveira-dos-Santos; Jeffery L Benovic; C Ronald Kahn; Seigo Izumo; Susan F Steinberg; Matthias P Wymann; Peter H Backx; Josef M Penninger
Journal:  Cell       Date:  2002-09-20       Impact factor: 41.582

4.  Gbetagamma-dependent phosphoinositide 3-kinase activation in hearts with in vivo pressure overload hypertrophy.

Authors:  S V Naga Prasad; G Esposito; L Mao; W J Koch; H A Rockman
Journal:  J Biol Chem       Date:  2000-02-18       Impact factor: 5.157

5.  Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction.

Authors:  Cinzia Perrino; Sathyamangla V Naga Prasad; Lan Mao; Takahisa Noma; Zhen Yan; Hyung-Suk Kim; Oliver Smithies; Howard A Rockman
Journal:  J Clin Invest       Date:  2006-06       Impact factor: 14.808

6.  Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.

Authors:  Benjamin J Wilkins; Yan-Shan Dai; Orlando F Bueno; Stephanie A Parsons; Jian Xu; David M Plank; Fred Jones; Thomas R Kimball; Jeffery D Molkentin
Journal:  Circ Res       Date:  2003-12-01       Impact factor: 17.367

Review 7.  Network integration of the adrenergic system in cardiac hypertrophy.

Authors:  Liza Barki-Harrington; Cinzia Perrino; Howard A Rockman
Journal:  Cardiovasc Res       Date:  2004-08-15       Impact factor: 10.787

8.  The "athletic heart". Prevalence and physiological significance of left ventricular enlargement in distance runners.

Authors:  W J Raskoff; S Goldman; K Cohn
Journal:  JAMA       Date:  1976-07-12       Impact factor: 56.272

9.  The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy.

Authors:  Ralph Knöll; Masahiko Hoshijima; Hal M Hoffman; Veronika Person; Ilka Lorenzen-Schmidt; Marie-Louise Bang; Takeharu Hayashi; Nobuyuki Shiga; Hideo Yasukawa; Wolfgang Schaper; William McKenna; Mitsuhiro Yokoyama; Nicholas J Schork; Jeffrey H Omens; Andrew D McCulloch; Akinori Kimura; Carol C Gregorio; Wolfgang Poller; Jutta Schaper; Heinz P Schultheiss; Kenneth R Chien
Journal:  Cell       Date:  2002-12-27       Impact factor: 41.582

10.  Inhibition of receptor-localized PI3K preserves cardiac beta-adrenergic receptor function and ameliorates pressure overload heart failure.

Authors:  Jeffrey J Nienaber; Hideo Tachibana; Sathyamangla V Naga Prasad; Giovanni Esposito; Dianqing Wu; Lan Mao; Howard A Rockman
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

View more
  14 in total

1.  miR-21 is associated with fibrosis and right ventricular failure.

Authors:  Sushma Reddy; Dong-Qing Hu; Mingming Zhao; Eddie Blay; Nefthi Sandeep; Sang-Ging Ong; Gwanghyun Jung; Kristina B Kooiker; Michael Coronado; Giovanni Fajardo; Daniel Bernstein
Journal:  JCI Insight       Date:  2017-05-04

2.  microRNA-133a attenuates cardiomyocyte hypertrophy by targeting PKCδ and Gq.

Authors:  Se-Yeon Lee; Chang Youn Lee; Onju Ham; Jae Yoon Moon; Jiyun Lee; Hyang-Hee Seo; Sunhye Shin; Sang Woo Kim; Seahyoung Lee; Soyeon Lim; Ki-Chul Hwang
Journal:  Mol Cell Biochem       Date:  2017-08-09       Impact factor: 3.396

3.  Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization.

Authors:  Fani Memi; Daniela Tirziu; Irinna Papangeli
Journal:  J Vis Exp       Date:  2018-09-15       Impact factor: 1.355

4.  Quantifying Drug-Induced Nanomechanics and Mechanical Effects to Single Cardiomyocytes for Optimal Drug Administration To Minimize Cardiotoxicity.

Authors:  Tao Yue; Ki Ho Park; Benjamin E Reese; Hua Zhu; Seth Lyon; Jianjie Ma; Peter J Mohler; Mingjun Zhang
Journal:  Langmuir       Date:  2016-02-05       Impact factor: 3.882

5.  Comparative analysis of mRNA isoform expression in cardiac hypertrophy and development reveals multiple post-transcriptional regulatory modules.

Authors:  Ji Yeon Park; Wencheng Li; Dinghai Zheng; Peiyong Zhai; Yun Zhao; Takahisa Matsuda; Stephen F Vatner; Junichi Sadoshima; Bin Tian
Journal:  PLoS One       Date:  2011-07-22       Impact factor: 3.240

Review 6.  Differential Role of Leptin and Adiponectin in Cardiovascular System.

Authors:  C M Ghantous; Z Azrak; S Hanache; W Abou-Kheir; A Zeidan
Journal:  Int J Endocrinol       Date:  2015-05-03       Impact factor: 3.257

Review 7.  Systematic Review of Metabolic Syndrome Biomarkers: A Panel for Early Detection, Management, and Risk Stratification in the West Virginian Population.

Authors:  Krithika Srikanthan; Andrew Feyh; Haresh Visweshwar; Joseph I Shapiro; Komal Sodhi
Journal:  Int J Med Sci       Date:  2016-01-01       Impact factor: 3.738

Review 8.  Growth differentiation factor 15 in adverse cardiac remodelling: from biomarker to causal player.

Authors:  Marian Wesseling; Julius H C de Poel; Saskia C A de Jager
Journal:  ESC Heart Fail       Date:  2020-05-18

Review 9.  The Hippo Signaling Pathway in Cardiac Development and Diseases.

Authors:  Masum M Mia; Manvendra K Singh
Journal:  Front Cell Dev Biol       Date:  2019-10-01

10.  Tissue doppler imaging can be useful to distinguish pathological from physiological left ventricular hypertrophy: a study in master athletes and mild hypertensive subjects.

Authors:  Giorgio Galanti; Loira Toncelli; Francesca Del Furia; Laura Stefani; Brunello Cappelli; Alessio De Luca; Maria Concetta Roberta Vono
Journal:  Cardiovasc Ultrasound       Date:  2009-10-21       Impact factor: 2.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.